Skip to main content

Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?

By Professor Piet van der Graaf, Ph.D., and Hugo Geerts, Ph.D.

Neurodegenerative diseases (NDs) affect millions of people worldwide. In the US alone, five million people suffer from Alzheimer disease; 1 million from Parkinson disease; 400,000 from multiple sclerosis (MS); and 30,000 each from amyotrophic (…)